HASHIMOTO THYROIDITIS PRESENTING WITH SHORT STATURE, PUBERTAL DISTURBANCE, AND TELOGEN EFFLUVIUM IN AN 11-YEAR-OLD GIRL": A CASE REPORT

Background: Hashimoto thyroiditis is the most common cause of acquired hypothyroidism in children and adolescents. Delayed diagnosis may lead to growth retardation, pubertal abnormalities, and other systemic manifestations. Early identification and appropriate management are essential to prevent long-term complications. Case Report: An 11-year-old female with newly diagnosed hypothyroidism presented with significant hair loss following initiation of levothyroxine therapy. Clinical evaluation revealed pathological short stature, history of early menarche with subsequent menstrual irregularity, and absence of progressive secondary sexual characteristics. Laboratory investigations showed low FT3 levels with elevated anti-thyroid peroxidase (135 IU/mL) and thyroglobulin antibodies (16.6 IU/mL), confirming Hashimoto thyroiditis. Mild anemia and acanthosis nigricans were also noted. The patient was managed with levothyroxine dose optimization, nutritional supplementation, and endocrine follow-up. Clinical pharmacist interventions included identification of a potential levothyroxine–iron interaction, evaluation of medication-related adverse effects, and recommendations for growth and pubertal monitoring. Conclusion: This case highlights the atypical presentation of Hashimoto thyroiditis with short stature, pubertal disturbance, and telogen effluvium in a pediatric patient. Early diagnosis, individualized thyroid hormone therapy, and multidisciplinary care are crucial for improving growth, pubertal development, and overall clinical outcomes.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-07-01
DOI
https://doi.org/10.5281/zenodo.21108815
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HASHIMOTO THYROIDITIS PRESENTING WITH SHORT STATURE, PUBERTAL DISTURBANCE, AND TELOGEN EFFLUVIUM IN AN 11-YEAR-OLD GIRL": A CASE REPORT

Yazhini S.*, Periya Karuppan A. R., Mageshwaran M., Visali K. et al.
Zenodo (CERN European Organization for Nuclear Research)
Thyroid Disorders and Treatments
article

HASHIMOTO THYROIDITIS PRESENTING WITH SHORT STATURE, PUBERTAL DISTURBANCE, AND TELOGEN EFFLUVIUM IN AN 11-YEAR-OLD GIRL": A CASE REPORT

Yazhini S.*, Periya Karuppan A. R., Mageshwaran M., Visali K., Dr. P. Monika
article en

Abstract

Background: Hashimoto thyroiditis is the most common cause of acquired hypothyroidism in children and adolescents. Delayed diagnosis may lead to growth retardation, pubertal abnormalities, and other systemic manifestations. Early identification and appropriate management are essential to prevent long-term complications. Case Report: An 11-year-old female with newly diagnosed hypothyroidism presented with significant hair loss following initiation of levothyroxine therapy. Clinical evaluation revealed pathological short stature, history of early menarche with subsequent menstrual irregularity, and absence of progressive secondary sexual characteristics. Laboratory investigations showed low FT3 levels with elevated anti-thyroid peroxidase (135 IU/mL) and thyroglobulin antibodies (16.6 IU/mL), confirming Hashimoto thyroiditis. Mild anemia and acanthosis nigricans were also noted. The patient was managed with levothyroxine dose optimization, nutritional supplementation, and endocrine follow-up. Clinical pharmacist interventions included identification of a potential levothyroxine–iron interaction, evaluation of medication-related adverse effects, and recommendations for growth and pubertal monitoring. Conclusion: This case highlights the atypical presentation of Hashimoto thyroiditis with short stature, pubertal disturbance, and telogen effluvium in a pediatric patient. Early diagnosis, individualized thyroid hormone therapy, and multidisciplinary care are crucial for improving growth, pubertal development, and overall clinical outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Zero hunger
Openalex Percentile: Top 8%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.